More on IDYA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-20.5% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

IDEAYA Biosciences (NQ:IDYA)
Delayed: 35.40 --0 (-0%)
Prev. Close $35.40  
Open$35.40 
52 Wk High$ 
52 Wk Low$ 
Day High$35.40 
Day Low$35.40 
P/E N/A  
EPS$ 
Volume424 

Friends, Peers and Foes (?): CATX, SMMT, EXAS, ILMN, IR (more...)

Jul 27, 2026 06:00 AM IDEAYA Biosciences starts Phase 1/2 expansion for IDE892 in cancer
Jul 27, 2026 06:00 AM IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancer
Jul 17, 2026 09:00 AM IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
Jul 9, 2026 04:57 PM Form 4 IDEAYA Biosciences, Inc. For: Jul 07 Filed by: Ruiz Briseno Andres
Jul 7, 2026 04:55 PM Form 144 IDEAYA Biosciences, Inc. Filed by: Ruiz Briseno Andres
Jul 7, 2026 08:00 AM Ideaya Biosciences (IDYA) PT Lowered to $48 at RBC Capital
Jul 7, 2026 07:09 AM Ideaya Biosciences (IDYA) PT Lowered to $63 at Truist Securities
Jun 26, 2026 06:00 AM IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 23, 2026 04:06 PM Form 8-K IDEAYA Biosciences, Inc. For: Jun 16
Jun 18, 2026 04:34 PM Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: YARNO WENDY L
View All Articles

Entities mentioned with IDYA

View All Entities